| Product Code: ETC7646174 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Bacteriophages Therapy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Bacteriophages Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Bacteriophages Therapy Market - Industry Life Cycle |
3.4 Israel Bacteriophages Therapy Market - Porter's Five Forces |
3.5 Israel Bacteriophages Therapy Market Revenues & Volume Share, By Targeted Bacteria, 2021 & 2031F |
3.6 Israel Bacteriophages Therapy Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Israel Bacteriophages Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Bacteriophages Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Bacteriophages Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibiotic-resistant infections |
4.2.2 Growing awareness about the effectiveness of bacteriophages therapy |
4.2.3 Rising investments in research and development of bacteriophages therapy |
4.3 Market Restraints |
4.3.1 Limited regulatory framework for bacteriophages therapy |
4.3.2 High costs associated with developing and manufacturing bacteriophages products |
4.3.3 Lack of standardized protocols and guidelines for bacteriophages therapy |
5 Israel Bacteriophages Therapy Market Trends |
6 Israel Bacteriophages Therapy Market, By Types |
6.1 Israel Bacteriophages Therapy Market, By Targeted Bacteria |
6.1.1 Overview and Analysis |
6.1.2 Israel Bacteriophages Therapy Market Revenues & Volume, By Targeted Bacteria, 2021- 2031F |
6.1.3 Israel Bacteriophages Therapy Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.1.4 Israel Bacteriophages Therapy Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.1.5 Israel Bacteriophages Therapy Market Revenues & Volume, By Streptococcus, 2021- 2031F |
6.1.6 Israel Bacteriophages Therapy Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.1.7 Israel Bacteriophages Therapy Market Revenues & Volume, By Salmonella, 2021- 2031F |
6.1.8 Israel Bacteriophages Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Bacteriophages Therapy Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Bacteriophages Therapy Market Revenues & Volume, By Urinary Tract Infections, 2021- 2031F |
6.2.3 Israel Bacteriophages Therapy Market Revenues & Volume, By Chronic Otitis, 2021- 2031F |
6.2.4 Israel Bacteriophages Therapy Market Revenues & Volume, By Chronic Ulcerative Colitis, 2021- 2031F |
6.2.5 Israel Bacteriophages Therapy Market Revenues & Volume, By Bone Infection, 2021- 2031F |
6.2.6 Israel Bacteriophages Therapy Market Revenues & Volume, By Wound and Skin Infections, 2021- 2031F |
6.2.7 Israel Bacteriophages Therapy Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.3 Israel Bacteriophages Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Bacteriophages Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Bacteriophages Therapy Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.4 Israel Bacteriophages Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 Israel Bacteriophages Therapy Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Bacteriophages Therapy Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Israel Bacteriophages Therapy Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Israel Bacteriophages Therapy Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Israel Bacteriophages Therapy Market Import-Export Trade Statistics |
7.1 Israel Bacteriophages Therapy Market Export to Major Countries |
7.2 Israel Bacteriophages Therapy Market Imports from Major Countries |
8 Israel Bacteriophages Therapy Market Key Performance Indicators |
8.1 Number of clinical trials conducted on bacteriophages therapy |
8.2 Research and development investments in bacteriophages therapy |
8.3 Number of partnerships and collaborations in the field of bacteriophages therapy |
8.4 Rate of adoption of bacteriophages therapy in healthcare facilities |
9 Israel Bacteriophages Therapy Market - Opportunity Assessment |
9.1 Israel Bacteriophages Therapy Market Opportunity Assessment, By Targeted Bacteria, 2021 & 2031F |
9.2 Israel Bacteriophages Therapy Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Israel Bacteriophages Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Bacteriophages Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Bacteriophages Therapy Market - Competitive Landscape |
10.1 Israel Bacteriophages Therapy Market Revenue Share, By Companies, 2024 |
10.2 Israel Bacteriophages Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here